Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.27% |
| 2 | Technology | 12.59% |
| 3 | Healthcare | 10.49% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Haemonetics
HAE
$3.86B
| $13.8M | 0.02% |
306,824
-68,124
| -18% | -$2.83M |
|
1027
Progress Software
PRGS
$1.71B
| $13.8M | 0.02% |
360,449
-270,758
| -43% | -$9.05M |
|
|
CBAY
1028
DELISTED
Cymabay Therapeutics
CBAY
| $13.7M | 0.02% |
1,703,124
+1,277,226
| +300% | +$8.64M |
|
1029
Element Solutions
ESI
$9.37B
| $13.7M | 0.02% |
1,228,291
+674,493
| +122% | +$8.35M |
|
1030
Skyworks Solutions
SWKS
$10.1B
| $13.7M | 0.02% |
134,149
+64,386
| +92% | +$6.68M |
|
1031
Jefferies Financial Group
JEF
$13B
| $13.7M | 0.02% |
604,449
-428,013
| -41% | -$9.59M |
|
1032
Invesco Mortgage Capital
IVR
$758M
| $13.7M | 0.02% |
79,703
+23,968
| +43% | +$4.04M |
|
1033
Travere Therapeutics
TVTX
$5.89B
| $13.6M | 0.02% |
548,334
+260,236
| +90% | +$5.73M |
|
1034
CALL
Albemarle
ALB
$14.8B
| $13.6M | 0.02% |
+100,000
| New | +$11.9M |
|
|
ULTI
1035
DELISTED
Ultimate Software Group Inc
ULTI
| $13.6M | 0.02% |
71,657
+23,779
| +50% | +$4.8M |
|
1036
News Corp Class A
NWSA
$16.1B
| $13.6M | 0.02% |
1,024,196
+707,194
| +223% | +$9.57M |
|
1037
CALL
XPO
XPO
$23B
| $13.6M | 0.02% |
578,279
| – | – |
|
1038
AAR Corp
AIR
$5.89B
| $13.5M | 0.02% |
358,200
+282,727
| +375% | +$10.2M |
|
1039
St. Joe Company
JOE
$3.84B
| $13.5M | 0.02% |
716,800
+702,831
| +5,031% | +$13.1M |
|
|
CQH
1040
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $13.5M | 0.02% |
538,765
+100,005
| +23% | +$2.56M |
|
1041
Brown & Brown
BRO
$23.8B
| $13.5M | 0.02% |
+558,548
| New | +$12.5M |
|
|
TCF
1042
DELISTED
TCF Financial Corporation Common Stock
TCF
| $13.4M | 0.02% |
257,376
-120,621
| -32% | -$5.76M |
|
|
RAVN
1043
DELISTED
Raven Industries Inc
RAVN
| $13.4M | 0.02% |
414,235
+93,561
| +29% | +$3.02M |
|
|
ESL
1044
DELISTED
Esterline Technologies
ESL
| $13.4M | 0.02% |
148,800
+127,815
| +609% | +$11.5M |
|
|
XLRN
1045
DELISTED
Acceleron Pharma
XLRN
| $13.4M | 0.02% |
359,304
-184,174
| -34% | -$6.39M |
|
1046
UFP Industries
UFPI
$5.19B
| $13.4M | 0.02% |
408,192
-86,253
| -17% | -$2.49M |
|
1047
Cullen/Frost Bankers
CFR
$10.2B
| $13.3M | 0.02% |
140,399
-101,240
| -42% | -$9.15M |
|
|
ITG
1048
DELISTED
Investment Technology Group Inc
ITG
| $13.3M | 0.02% |
601,878
-58,163
| -9% | -$1.22M |
|
1049
Hanover Insurance
THG
$8.06B
| $13.3M | 0.02% |
137,445
-404,049
| -75% | -$38.4M |
|
|
SPLK
1050
CALL
DELISTED
Splunk Inc
SPLK
| $13.3M | 0.02% |
+200,000
| New | +$12.5M |
|
Similar funds
Millennium Management's Q3 2017 Portfolio in Review
As of Q3 2017, Millennium Management held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Millennium Management deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Millennium Management's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Millennium Management added most to Salesforce in Q3 2017, an estimated $208M increase.
- Millennium Management's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Millennium Management fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Millennium Management's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Millennium Management opened 794 new positions and closed 737 in Q3 2017.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.